» Articles » PMID: 1346069

Human Immunodeficiency Virus (HIV) Type 1 Can Superinfect HIV-2-infected Cells: Pseudotype Virions Produced with Expanded Cellular Host Range

Overview
Specialty Science
Date 1992 Jan 1
PMID 1346069
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

In studies on viral interference, cloned T-cell lines chronically infected with human immunodeficiency virus (HIV) type 1 or HIV-2 were inoculated with several strains of these two AIDS retrovirus subtypes. HIV-2UC1-infected cells, which still express the CD4 receptor, could be superinfected with a variety of HIV-1 and HIV-2 strains. This event was accompanied by cytopathic effects in the cells and production of pseudotype virions with an expanded cellular host range. HIV-1- or HIV-2-infected clonal cell lines, which did not express CD4, could not be superinfected by any HIV strains but were coinfected after transfection of molecular clones into the persistently infected cells. These observations indicate that viral interference with HIV occurs at the cell surface and involves a down-modulation of the CD4 molecule. If the CD4 protein is expressed, superinfection can take place, and phenotypically mixed virus particles are produced. Since HIV-1 and HIV-2 dually infected individuals have been detected, these in vitro observations may have relevance to the in vivo state.

Citing Articles

Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level.

Acchioni C, Sandini S, Acchioni M, Sgarbanti M Pathogens. 2024; 13(5).

PMID: 38787201 PMC: 11124504. DOI: 10.3390/pathogens13050349.


Viral Coinfections.

Du Y, Wang C, Zhang Y Viruses. 2022; 14(12).

PMID: 36560647 PMC: 9784482. DOI: 10.3390/v14122645.


Slow Receptor Binding of the Noncytopathic HIV-2 Envs Is Balanced by Long-Lived Activation State and Efficient Fusion Activity.

Harris M, Ratnapriya S, Chov A, Cervera H, Block A, Gu C Cell Rep. 2020; 31(10):107749.

PMID: 32521274 PMC: 7336836. DOI: 10.1016/j.celrep.2020.107749.


CD4 Incorporation into HIV-1 Viral Particles Exposes Envelope Epitopes Recognized by CD4-Induced Antibodies.

Ding S, Gasser R, Gendron-Lepage G, Medjahed H, Tolbert W, Sodroski J J Virol. 2019; 93(22).

PMID: 31484748 PMC: 6819941. DOI: 10.1128/JVI.01403-19.


Virological and Immunological Outcomes of Coinfections.

Kumar N, Sharma S, Barua S, Tripathi B, Rouse B Clin Microbiol Rev. 2018; 31(4).

PMID: 29976554 PMC: 6148187. DOI: 10.1128/CMR.00111-17.


References
1.
Evans L, Moreau J, Odehouri K, Seto D, Legg H, Barboza A . Simultaneous isolation of HIV-1 and HIV-2 from an AIDS patient. Lancet. 1988; 2(8625):1389-91. DOI: 10.1016/s0140-6736(88)90586-7. View

2.
Kaminsky L, McHugh T, Stites D, Volberding P, Henle G, Henle W . High prevalence of antibodies to acquired immune deficiency syndrome (AIDS)-associated retrovirus (ARV) in AIDS and related conditions but not in other disease states. Proc Natl Acad Sci U S A. 1985; 82(16):5535-9. PMC: 391157. DOI: 10.1073/pnas.82.16.5535. View

3.
Evans L, McHugh T, Stites D, Levy J . Differential ability of human immunodeficiency virus isolates to productively infect human cells. J Immunol. 1987; 138(10):3415-8. View

4.
Tersmette M, de Goede R, Al B, Winkel I, Gruters R, Cuypers H . Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J Virol. 1988; 62(6):2026-32. PMC: 253287. DOI: 10.1128/JVI.62.6.2026-2032.1988. View

5.
Levy J, Tobler L, McHugh T, Casavant C, Stites D . Long-term cultivation of T-cell subsets from patients with acquired immune deficiency syndrome. Clin Immunol Immunopathol. 1985; 35(3):328-36. DOI: 10.1016/0090-1229(85)90093-5. View